Discover assets across development and commercial stages, supported by documentation and execution discipline needed for regulated and emerging markets.
| Product | Therapy | Dosage |
Phase 1: INITIAL DISCOVERY Phase 2: PROTOTYPE COMPLETION Phase 3: EXHIBIT BATCH STAGE Phase 4: DOSSIER FILED Phase 5: COMMERCIALISED |
|---|---|---|---|
| Decitabine | Oncology | Lyophilised | Phase 5: COMMERCIALISED |
| Parecocib | COX-2 Inhibitor | Lyophilised | Phase 5: COMMERCIALISED |
| Sugammadex | CNS | Liquid | Phase 5: COMMERCIALISED |
| Tigecycline | Antibiotic | Lyophilised | Phase 1: INITIAL DISCOVERY |
| Posaconazole | Antifungal | Liquid | Phase 4: DOSSIER FILED |
| Isavuconazole | Antifungal | Lyophilised | Phase 4: DOSSIER FILED |
Ready-to-transfer packages backed by disciplined development and documentation, so partners can move from handover to production with confidence.